Correlation Between Cue Biopharma and Silence Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Silence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Silence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Silence Therapeutics PLC, you can compare the effects of market volatilities on Cue Biopharma and Silence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Silence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Silence Therapeutics.
Diversification Opportunities for Cue Biopharma and Silence Therapeutics
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cue and Silence is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Silence Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silence Therapeutics PLC and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Silence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silence Therapeutics PLC has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Silence Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Silence Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.29 times more return on investment than Silence Therapeutics. However, Cue Biopharma is 1.29 times more volatile than Silence Therapeutics PLC. It trades about 0.0 of its potential returns per unit of risk. Silence Therapeutics PLC is currently generating about 0.0 per unit of risk. If you would invest 308.00 in Cue Biopharma on September 2, 2024 and sell it today you would lose (186.00) from holding Cue Biopharma or give up 60.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Silence Therapeutics PLC
Performance |
| Timeline |
| Cue Biopharma |
| Silence Therapeutics PLC |
Cue Biopharma and Silence Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Silence Therapeutics
The main advantage of trading using opposite Cue Biopharma and Silence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Silence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silence Therapeutics will offset losses from the drop in Silence Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Silence Therapeutics vs. Tff Pharmaceuticals | Silence Therapeutics vs. Eliem Therapeutics | Silence Therapeutics vs. Inhibrx | Silence Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |